SIDE POPULATION (SP) cells are identified based on an absence of staining to the vital dye Hoechst 33342 (5) . During flow cytometry analysis, SP cells are visualized as a negatively stained "side population" on a density dot plot. Bone marrow (BM) SP cells express the stem cell markers Sca-1 (stem cell antigen) and c-kit and lack expression of mature hematopoietic cell markers (5, 6, 18) . Notably, BM SP cells are highly enriched for hematopoietic stem cell (HSC) activity. In fact, only 200 SP cells are required to fully reconstitute the BM of a lethally irradiated mouse (5) . Recent studies suggest that BM SP cells possess the capacity to reconstitute nonhematopoietic tissues (8, 10) . In these studies, SP cells contributed to the repair of injured skeletal muscle, cardiac muscle, and endothelial cell types.
Targeted gene ablation in mice indicated that the ATP binding cassette-transporter protein breast cancer resistance protein (Bcrp1) mediates Hoechst efflux; SP cells are not detected in Bcrp1-null mice (24, 25) . Despite this, Bcrp1-deficient mice have a normal number of functional HSCs (24) . This indicates that Bcrp1 serves as a marker of SP cells but is not required for stem cell function.
Recently, SP cells have been identified in nonhematopoietic tissues, including skeletal muscle, testes, mammary gland, and lung (2, 12, 15, 19, 22) . Tissue SP cells share phenotypic features with BM SP cells, such as the expression of Sca-1, and the absence of expression of mature hematopoietic markers. Tissue SP cells can be distinguished from BM SP cells on the basis of their heterogeneity in their expression of the panhematopoietic marker CD45 (1) . The percentage of CD45-positive and -negative SP cells varies between tissues.
In the lung, SP cells comprise Ͻ0.1% of digests, a percentage that remains fixed from postnatal day 5 to 1 yr of age (19) . To date, the anatomical location of lung SP cells is unknown. The inability to definitively localize lung SP cells in tissue sections relates to the rarity of the population and the expression of Bcrp1 and Sca-1 in multiple lung cell types (11, 19) . Similar to SP cells identified in other tissues, lung SP cells variably express CD45. Previous studies report that ϳ75% of lung SP cells express the pan-hematopoietic marker CD45 (19) . This observation is consistent with accumulating data suggesting a marrow origin for some tissue stem cells (13, 14) .
In this paper, we set out to examine the origin of lung SP cells and to further characterize the relative differences in CD45-positive and -negative subtypes. Using several BM transplantation models, we found that both lung SP cell subtypes are marrow derived. Despite having a common origin, lung (CD45-positive and -negative) and BM SP cells represent three phenotypically distinct cell populations. These results suggest distinct roles for CD45-positive and CD45-negative SP cells in lung tissue homeostasis.
METHODS

Animals.
Lung suspensions were prepared from adult mice (4 -8 wk of age) of backgrounds C57BL/6J, C57BL/6-TgN (ACT-EGFB), and 10sb/J (Jackson Laboratories, Bar Harbor, MA), and the mixed background 129/O1a/C57BL/6 (Bcrp1-deficient mice). Bcrp1-deficient mice were kindly provided by Dr. Brian Sorrentino (St. Jude Children's Research Hospital, Memphis, TN) (24) . Animals were killed by isoflurane anesthesia followed by cervical dislocation. Animal studies were conducted according to protocols approved by the National Institutes of Health and the Boston University Animal Care and Use Committee.
Transplant studies. BM transplantation was performed in lethally irradiated mice (14 gray of ␥-irradiation in split dose) utilizing 20 million whole bone marrow (WBM) cells isolated from 6-to 8-wk-old C57BL/6, C57BL/6-TgN (ACT-EGFB), or Bcrp1-deficient mice and delivered by tail vein injection. Transplant of BM SP cells was performed by injecting 200 BM SP cells isolated from C57BL/6-TgN (ACT-EGFB) mice mixed with 200 ϫ 10 3 nucleated WBM cells prepared from 6-to 12-wk-old C57BL/6J mice. Cells were delivered by retroorbital injection. Recipient mice were maintained on acidified or antibiotic water and autoclaved food.
Cell preparations and staining. Cell suspensions were obtained from enzyme-digested lungs as previously described (19) . Briefly, before lung extraction, animals were bled by transecting the abdominal aorta. Next, in an attempt to remove circulating blood cells, perfusion of the pulmonary vasculature was performed using ice-cold saline until the lungs bleached white. Lung extracts were then digested by finely mincing tissue with a razor blade in the presence of 0.1% collagenase (Roche Diagnostics, Indianapolis, IN), 2.4 U/ml dispase (Roche Diagnostics), and 2.5 mM CaCl 2 at 37°C for 1 h. Removal of nonspecific debris was accomplished by sequential filtration through 70-and 40-m filters. Cells were resuspended at a concentration of 10 ϫ 10 6 cells/ml. Hoechst 33342 (5 g/ml; Sigma-Aldrich, St. Louis, MO) staining of lung and BM cells was performed at 37°C for 90 min in DMEM supplemented with 2% fetal calf serum (FCS), 10 mM HEPES, and 1% penicillin/streptomycin (5, 19) . At the completion of staining, cells were immediately placed on ice. Immunostaining was performed in the dark at 4°C for 30 min using directly fluorochrome-conjugated monoclonal rat anti-mouse antibodies reactive to CD45 (BD Pharmingen, Lexington, KY). After staining, cells were washed twice and resuspended in Hanks' balanced salt solution supplemented with 2% FCS. Dead cells were excluded from flow cytometry analysis based on propidium iodide staining (2 g/ml). In all studies, dead cells comprised Ͻ10 -15% of total cells. An isotype control antibody for CD45 was employed as a negative control and to establish gating parameters for positive cells.
Fluorescence-activated cell sorting. Flow cytometry analysis of Hoechst-stained cells was performed on a triple laser instrument (MoFlo; Cytomation, Fort Collins, CO). An argon multiline UV (333-363 nm) laser was used to excite Hoechst dye. Fluorescence emission was collected with a 405/30 band-pass filter (Hoechst blue) and a 660 long-pass filter (Hoechst red). A second 488-nm argon laser was used to excite phycoerythrein, green fluorescent protein (GFP), and propidium iodide. Data analysis was performed using Summit software.
RT-PCR. cDNA was generated from RNA extracts derived from 11,000 CD45-positive and -negative lung SP cells, or BM SP cells, with a reverse transcription kit (Promega, Madison, WI). PCR was performed using the following primers: GATA-1 primers 5Ј-CCAAT-GCACTAACTGTCAAACG-3Ј and 5Ј-CATGCCTGAATCTCAG-TACTCG-3Ј, GATA-2 primers 5Ј-AACTGCATAAGCTTAAC-CCGC-3Ј and 5Ј-GGTTGACTCAGCACAATCGTC-3Ј, PU.1 primers 5Ј-ACAGATGCACGTCCTCGATAC-3Ј and 5Ј-GGAACTGGTAC-AGGCGAATCT-3Ј, ␣-Sma (␣-smooth muscle actin) primers 5Ј-AGCTTTGGGCAGGAATGATTTGG-3Ј and 5Ј-AAGATCATTGC-CCCTCCAGAACG-3Ј, keratin 18 primers 5Ј-GGCCACTACTTCAA-GATCATC-3Ј and 5Ј-GTACTTGTCCAGTTCCTCGCG-3Ј, keratin 19 primers 5Ј-CTACAGATTGACAATGCTCGC-3Ј and 5Ј-GGATCTT-GGCTAGGTCGACAC-3Ј, keratin 23 primers 5Ј-GACACTGAAGG-GACGATGGAT-3Ј and 5Ј-GTCGAGACTCACCCATTAGCG-3Ј, and ␤-actin primers 5Ј-GCTCGTTGCCAATAGTGATG-3Ј and 5Ј-AAG-AGAGGTATCCTGACCCT-3Ј. Cycling conditions for ␣-Sma, keratin 18, and ␤-actin were 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min, 35 cycles. Cycling conditions for keratin 19, keratin 23, GATA-1, GATA-2, and PU.1 were 94°C for 1 min, 54°C for 1 min, and 72°C 1 min, 35 cycles.
Immunohistochemistry. Collected lung SP cells were cytospun onto charged slides, fixed with acetic acid/methanol (1:3) for 5 min, and washed in PBS. Hematoxylin (filtered) staining was performed at a 1:9 dilution for 1 min. Immunostaining of SP cells was done using an immunofluorescent detection method. Before staining, cells were quenched with sodium borohydride. Fluorescent staining was carried out using a fluorochrome-conjugated monoclonal antibody against the acidic forms of cytokeratin (Clone C-11; Sigma-Aldrich) and ␣-Sma (Sigma-Aldrich). In parallel slides, isotype control antibodies were used to immunostain cytospun SP cells. After staining, slides were washed in PBS, and nuclear counterstaining was performed using 4Ј,6Ј-diamidino-2-phenylindole dihydrochloride (Sigma-Aldrich). The percentage of positive cells for each marker was determined from averaging the values obtained from three independent investigators counting 100 cells.
RESULTS
Lung SP cells originate from the BM.
We employed several different transplantation models to determine whether lung SP cells originate from the BM. Utilizing recipient mice that lacked detectable SP cells (Bcrp1-deficient mice), we performed transplantation studies with wild-type or Bcrp1-deficient BM cells. Six months after transplantation, lungs were isolated, digested, stained with Hoechst dye, and then analyzed by flow cytometry. As anticipated, lung SP cells were not detected in Bcrp1-deficient mice transplanted with Bcrp1-deficient BM cells (n ϭ 2). However, in mice receiving wild-type BM cells (n ϭ 2), a visible SP band was detected (Fig. 1) . Importantly, the fraction of SP cells (0.09%) was similar to that detected in previous reports, and both CD45-positive and -negative cells were present in the SP gate.
We next transplanted donor GFP-expressing BM cells into wild-type mice. After 8 mo (n ϭ 4), lungs were digested, stained with Hoechst dye, and analyzed by flow cytometry. In all four transplant recipients, GFP-expressing CD45-positive and CD45-negative cells were detected in the SP fraction (Fig. 2) . (Fig. 3) . Together, these studies demonstrate that CD45-positive and -negative lung SP cells originate from the BM.
Morphological characteristics of lung and BM SP cells. To further characterize the relationship between marrow and lung SP cells, we examined their morphological characteristics. For this, SP cells isolated by high-speed cell sorting were fixed onto glass slides before hematoxylin staining. Examination of BM SP cells revealed a uniform population of well-circumscribed cells averaging 10 m in size. In addition, BM SP cells had a large nuclear to cytoplasmic ratio and possessed scant cytoplasm (Fig. 4) . Similar morphological characteristics were noted in CD45-positive lung SP cells; however, on average, CD45-positive lung SP cells were smaller, averaging 7 m in size. CD45-negative lung SP cells were easily distinguished from BM and CD45-positive lung SP cells based on size and shape; these cells were larger, averaging 15-20 m in size, had an oval shape, and possessed abundant cytoplasm with extensive granularity (Fig. 4) .
Hematopoietic transcription factor expression in lung and BM SP cells. Previous work demonstrated that BM SP cells are highly enriched for hematopoietic stem cell activity (5) . To further characterize the relationship between BM and lung SP cells, we therefore examined the expression of several key hematopoietic transcription factors in each population. To do this, we performed RT-PCR on CD45-positive and -negative lung SP cells and on equal numbers of BM SP cells. In these studies, we first characterized GATA-2, which is involved in maintaining the undifferentiated state of HSCs (20, 21) . We found that GATA-2 was expressed by CD45-positive lung SP cells and BM SP cells but was not expressed by CD45-negative lung SP cells. CD45-positive lung SP cells were distinguished from BM SP cells by the expression of the transcription factor PU.1. All three SP cell populations were negative for GATA-1, a critical factor in regulating the differentiation of erythroid progenitors (Fig. 5) (26) .
Expression of epithelial and mesenchymal markers in lung and BM SP cells. We next examined whether lung SP cells express markers of mesodermal or endodermal derivatives. For this, we immunostained CD45-positive and -negative lung SP cells for ␣-Sma and cytokeratin (Fig. 6A) . The majority of CD45-positive lung SP cells were cytokeratin positive/␣-Sma positive (53%). In contrast, CD45-negative lung SP cells were predominantly cytokeratin negative (95%) but ␣-Sma positive (58%) (Fig. 6B) .
We subsequently examined the expression of ␣-Sma and cytokeratin in SP cells isolated from BM (Fig. 6A) . In these studies, we determined that BM SP cells were a heterogeneous population of cells based on their expression of these proteins. Approximately 55% of all BM SP cells did not express either cytokeratin or ␣-Sma. The remaining cells were found to be positive for ␣-Sma, of which 22% percent coexpressed cytokeratin (Fig. 6B) . In both the lung and BM, we did not identify any SP cell expressing cytokeratin alone. Expression of cytokeratin and ␣-Sma genes was confirmed by RT-PCR (Fig. 7) . To do this, we performed BM transplantation studies and examined for the presence of donor-derived cells within the lung SP gate. These studies found that CD45-positive as well as CD45-negative lung SP cells were BM derived. We also performed transplantation studies utilizing highly purified CD45ϩ, Sca-1ϩ, c-kitϩ, and lineage negative BM SP cells. These studies showed that CD45-positive and -negative lung SP cells could be derived from marrow SP cells. Although marrow SP cells are uniformly CD45 positive, we cannot definitively exclude the possibility of a contaminating CD45-negative stem cell contributing to our findings. Despite the small percent of donor-derived CD45-negative lung SP cells in our transplantation experiments, these results were reproducible in four separate animals. The differential turnover or sensitivity of CD45-positive and -negative lung SP cells to radiation may contribute to the kinetics of BM-dependent reconstitution. Importantly, the variable expression of GFP in donor cells (75-85%) limits our ability to absolutely quantify the engraftment potential of BM SP cells.
The ability of BM SP cells to reconstitute tissue SP cells has been documented in sites other than the lung. In skeletal muscle, SP cells were found to be 90% BM derived 12 mo posttransplantation, although the relative contribution to CD45-positive and -negative subsets was not characterized in these studies (14, 15) . Whether BM SP cells serve as a source for the reconstitution of SP cells residing within other tissues is unclear. A recent study demonstrated that the contribution of BM cells to the testes SP fraction was negligible (Ͻ5%) (12) . In this study, total body irradiation was not a component of the experimental protocol; this suggests that tissue injury may be required for tissue SP cell reconstitution.
To further examine the relationship of lung and BM SP cells, we compared the morphological characteristics of each population. Except for small differences in cell size, which may be a consequence of enzymatic digestion, CD45-positive lung SP cells and BM SP cells were indistinguishable. These shared characteristics may reflect functional similarities between the two populations or their developmental proximity. Interestingly, CD45-negative lung SP cells were easily distinguished from BM and CD45-positive lung SP cells based on histological analysis. Of note, CD45-negative lung SP cells do not resemble mature lung (i.e., type I, type II cells) or hematopoietic cell types. Attempts to localize SP cells in lung tissue sections have thus far been unsuccessful due in part to the rarity of the population and the absence of SP cell-specific markers. Insight into the physiological role of CD45-negative SP cells may require genetic profiling and the identification of its anatomical niche within the lung.
Having established that lung SP cells were derived from BM, we evaluated whether lung SP cells express genes characteristic of hematopoietic stem/progenitor cells. To do this, we performed RT-PCR to survey expression of the hematopoietic transcription factors GATA-1, GATA-2, and PU.1. As expected, BM SP cells expressed only GATA-2, a factor critical for the maintenance of HSCs (20, 21) . In contrast, CD45-positive lung SP cells expressed both GATA-2 and PU.1, an expression pattern characteristic of myeloid progenitor cells, whereas CD45-negative lung SP cells did not express any of the three transcription factors examined (26) . On the basis of this, we speculate that CD45-positive lung SP cells are local progenitors for myeloid cells in the lung, such as macrophages, mast cells, and eosinophils.
To begin to examine the expression of epithelial and mesenchymal genes in lung SP cells, we performed immunostaining using monoclonal antibodies to pan-cytokeratin and ␣-Sma. These studies demonstrate that within each population of SP cells, there exists significant heterogeneity. Interestingly, we found that subpopulations of BM SP cells also express cytokeratin and ␣-Sma proteins. These findings are consistent with gene profiling studies on highly purified BM SP cells (17) . The relationship of marrow SP cells to local organ progenitor cells is a focus of future study. Cells of a similar phenotype, termed myoepithelial cells, have been identified in various tissues and have been found to play an important role in tissue homeostasis and the pathogenesis of disease (3, 4, 7, 16) .
In conclusion, we confirmed that adult lung SP cells arise from the BM and that both the CD45-positive and -negative cell types can be derived from a uniform purified population of HSCs (BM SP cells). These data thus suggest that local environmental cues induce these subtypes into phenotypically distinct cell populations. We speculate that CD45-positive and -negative lung SP cells have unique biological roles within the lung and that dysregulation of either population may contribute to the pathogenesis of various lung diseases.
